The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]
-
Correspondence: The FIELD Study Investigators tony@ctc.usyd.edu.au
Cardiovascular Diabetology 2004, 3:9 doi:10.1186/1475-2840-3-9
No comments have yet been made on this article.